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CASE STUDY
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Abstract
A 35-year-old man with an enhancing tumefactive brain lesion underwent
biopsy, revealing inflammatory demyelination. We used quantitative GradientRecalled-Echo (qGRE) MRI to visualize and measure tissue damage in the
lesion. Two weeks after biopsy, qGRE showed significant R2t* reduction in the
left optic radiation and surrounding tissue, consistent with the histopathological
and clinical findings. qGRE was repeated 6 and 14 months later, demonstrating
partially recovered optic radiation R2t*, in concert with improvement of the
hemianopia to ultimately involve only the lower right visual quadrant. These
results support qGRE metrics as in vivo biomarkers for tissue damage and longitudinal monitoring of demyelinating disease.
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Introduction
The pathology of multiple sclerosis (MS) is heterogeneous, encompassing varying degrees of demyelination,
inflammation, and axonal injury in both white and gray
matter (WM/GM).1 Standard clinical MRI does not correlate well with MS clinical disability,2,3 partly because it
cannot discern the severities of these pathologies, and
cannot detect abnormalities due to MS that are not sufficiently large or conspicuous. Moreover, areas that appear
normal are often abnormal by histopathology; these
regions are known as “normal-appearing” WM and GM
(NAWM/NAGM). Thus, improved imaging biomarkers of
MS tissue damage and repair are needed to better understand the evolution of MS pathology, and to facilitate the
search for effective treatments. While different MRI-based
methods have been proposed over the years for evaluation
of MS-related tissue damage, a consensus on their application in clinical practice is still a work in progress.4

We have previously proposed gradient echo imaging to
measure T2* (1/R2*) of brain tissue as an in vivo biomarker for quantitative evaluation of tissue damage in
MS.5 Our measurements demonstrated significant R2*
reductions in patients with MS. This result is in agreement with prior R2 (1/T2) measurements which correlated with white matter damage.6 To better understand
the meaning of R2* reductions in MS-affected tissue, in
this report we use recently developed quantitative gradient recalled echo (qGRE) MRI in a biopsied inflammatory
demyelinating brain lesion.7 The qGRE method separates
the tissue-cellular-specific R2t* from the total GRE signal
decay R2*, as total R2* can be altered by macroscopic
field inhomogeneities and blood oxygen level-dependent
effect (BOLD), affected by fluctuating physiological activity. Therefore, R2t* reflects tissue conditions more specifically than R2* in both white and gray matter of central
nervous system (CNS). Our previous studies revealed a
quantitative relationship between R2t* and normal
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cortical neuronal density defined based on genetic information from the Allen Human Brain Atlas.8 We also
reported reduced R2t* in MS NAGM, NAWM, and in
WM MS lesions, finding that the extent of R2t* reductions correlated with the severity of upper extremity dysfunction and cognitive test scores.9
Herein, we demonstrate relationships of qGRE measurements with neuropathology findings in a person with a
large parieto-occipital lesion who underwent biopsy and
was found to have inflammatory demyelination. Furthermore, we show the evolution of the qGRE metrics over a
period of 14 months correlated with the clinical evolution.

Methods
The Institutional Review Board of Washington University
approved the MRI protocol. A 35-year-old right-handed
man presented with right homonymous hemianopia and
aphasia. MRI demonstrated a large left contrast-enhancing
parieto-occipital lesion with mass effect on the posterior
horn of the left lateral ventricle, along with two smaller
nonspecific subcortical T2-weighted hyperintensities in
the left frontal lobe. Spinal cord MRI was negative. Cerebrospinal fluid (CSF) studies revealed 29 nucleated cells
(89% lymphocytes, 11% monocytes) and 6 CSF-restricted
oligoclonal bands with normal IgG index (0.59). Comprehensive blood evaluations for infectious, rheumatologic,
metabolic, and autoimmune disorders, including NMOIgG, anti-MOG, and HIV tests, were negative. He was
empirically treated with intravenous methylprednisolone
followed by oral corticosteroids. Yet, repeat MRI 1 month
later showed the lesion to be larger with extensive heterogeneous enhancement and greater mass effect. Because of
the atypical course and worsening MRI, brain biopsy was
performed 8 weeks after clinical onset. For tissue evaluation, histopathologic and immunohistochemical stains
included Luxol fast blue–periodic acid Schiff (LFB-PAS;
myelin), antibodies to neurofilament protein (axons),
CD3 (T cells), CD163 (monocyte/macrophage, activated
microglia), glial fibrillary acidic protein (GFAP) (activated
astrocytes), and Prussian Blue (iron).
qGRE MRI scan was performed at 2 weeks, 6 months
and 14 months after the biopsy using a 3T Prisma MRI

(Siemens, Germany). qGRE data were acquired using
three-dimensional multigradient echo sequence with flip
angle 30°, TR = 50 ms, voxel size 1 9 192 mm3 and
acquisition time 12 min. Ten gradient echoes, with first
echo time TE1 = 4 ms and echo spacing DTE = 4 ms
were collected. In addition, Fluid-attenuated inversion
recovery (FLAIR) images (voxel size 1 9 1 9 3 mm3)
and magnetization-prepared rapid gradient echo
(MPRAGE) (voxel size 1 9 1 9 1 mm3) were acquired.
Quantitative R2t* images were generated using previously described methods.8 For each visit, MPRAGE and
FLAIR images were registered using FSL 5.0.0 software
(Analysis Group, FMRIB, Oxford, UK)10 and employed
to obtain WM lesion masks using the “lesion-TOADS”
tool11 in Medical Image Processing, Analysis and Visualization (MIPAV).12 The tissue damage score (TDS) for
each voxel in the lesions was calculated as follows:
TDS ¼



R2tcontrol
 R2tlesion


R2tcontrol  R2tCSF

(1)

where R2t*CSF is the R2t* value in the CSF (near zero),
R2t*lesion are the R2t* values in the lesion’s voxels, and
R2t*control is the “normal reference” R2t* value. For the
latter, we collected qGRE data on three age- and gendermatched healthy control subjects. The median value of
R2t* in the total white matter of the three healthy ageand gender-matched control subjects was computed
(20.1 s1) and used as the “control reference.” Since
inflammatory demyelination damages tissue, it leads to
decreased R2t*. Consequently, the TDS in the lesion is
positive, approaching 1 in completely destroyed tissue
void of macromolecules, similar to CSF. The mean TDS
in the parietal-occipital lesion was calculated by averaging
TDS in each voxel with exclusion of the biopsy needle
path. In this study, the large parieto-occipital lesion was
analyzed separately from the two small lesions in the left
frontal lobe.
To better visualize the contribution of the optical radiation to R2* signal, we used a two-compartment model
in which the free water contribution within R2* (set to
1 s1 same as CSF) was filtered out, with the remainder,
which we have termed R2c* relaxation, closely

Figure 1. Biopsied parieto-occipital lesion in left hemisphere revealed inflammatory demyelination. (A): Image of a hematoxylin and eosin (H&E,
4x magnification) stained biopsy specimen shows central regions of patchy pallor of the white matter, with an edge of normal white matter (at
left lower edge) and perivascular mononuclear cell cuffing which is better visualized at higher magnification (20x) in (B). (C): An adjacent section
stained with Luxol fast blue–periodic acid Schiff (LFB-PAS, 4x magnification) shows loss of myelin (loss of deep purple color). (D): Higher
magnification (LFB-PAS, 20x) of the central demyelinated area shows little remaining myelin and macrophages with engulfed debris. (E): An
adjacent section immunostained for neurofilaments (4x magnification) demonstrates relative sparing of axons in the area lacking myelin. (F):
Higher magnification of (E) shows mainly normal-appearing axons (brown stain). (G): An adjacent section immunostained for CD3 reveals
numerous perivascular CD3+ T cells (brown stain). (H): Prussian Blue staining (20x) for iron accumulation was negative. (I) CD163 staining for
monocytes and activated microglia reveals numerous positive cells. (J) Glial fibrillary acidic protein (GFAP) staining shows activated astrocytes with
reactive cytoplasm (gemistocytes) and numerous processes.
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representing the contribution of cells and cellular processes. This approach is similar to free water mapping
using diffusion MRI.13

Results
Microscopic images of the biopsied lesion (Fig. 1) showed
regions of increased mononuclear cells, many of which
were CD3+ T cells, along with highly reduced LFB-PAS
stain indicating extensive demyelination. Relative preservation of neurofilament immunostaining (axons) was seen.
This staining constellation indicated an inflammatory
demyelinating process with relative axonal preservation.
Axonal density was not measured as it was confounded by
numerous intercalated macrophages and gliosis. Prussian
Blue staining showed no iron accumulation within the
biopsy (Fig. 1H). GFAP-positive activated astrocytes with
numerous processes were present (Fig. 1J).
Five months postbiopsy, speech and language function
had returned almost to normal, but the dense right
homonymous hemianopia persisted. A clinical MRI at
that time showed the left parieto-occipital lesion still present, but without Gd enhancement, with reduced mass
effect and smaller FLAIR contrast size. Ten months postbiopsy, the patient was started on dimethyl fumarate for
presumed MS. Fourteen months postbiopsy, clinical
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examination revealed normal speech except for rare
word-finding difficulty and only an inferior right quadrantanopia. Clinical FLAIR images show the tumefactive
as well as two nonspecific lesions (Figure S1A).
qGRE measurements at 2 weeks, 6 months, and
14 months after biopsy revealed the left parieto-occipital
lesion with reduced R2t*, compared with surrounding
tissue and the contralateral NAWM (Fig. 2C,H,L). This
reduction was quantitatively characterized by TDS
(Fig. 2D,I,M), with higher TDS values indicating worse
tissue disruption. Over the 14 months, a substantial
decrease in the lesion size and mean TDS, as well as the
heterogeneity of the damage within the lesion, were
observed. At the same time, the R2t* value in the contralateral side of the biopsied lesion remained stable
across three visits (Figure S2A). The volume and the
mean TDS of the other two small lesions (combined)
over the three visits were 258 mm3 and 0.29, 128 mm3
and 0.28, 104 mm3 and 0.28, indicating progressive lesion
size reduction.
R2c* images revealed a normal bright right optic
radiation (red arrows in Fig. 2F,J,N). At visit 1, contrast between left optic radiation and surrounding tissue
was reduced compared with the right side (Fig. 2F). By
visit 2 and 3 the left optic radiation was becoming
more visible.

Figure 2. qGRE analyses of biopsied left parieto-occipital lesion. MRI data of visit 1, visit 2, and visit 3 were collected 2 weeks, 6 months, and
14 months after biopsy, respectively. The patient was started on dimethyl fumarate 10 months after biopsy. MRI images in visit 2 and 3 were
registered to MRI images in visit 1. (A), (G), (K): FLAIR images showed the progressively reduced size of the left parieto-occipital lesion at visit 2
after 6 months and visit 3 after 14 months. (B). Lesion volume of the biopsied left parieto-occipital lesion decreased over the three visits. (C), (H),
(L): R2t* images showed damaged optic radiation in the left hemisphere (yellow arrows vs. red arrows pointed to the intact right optic radiation)
and bright biopsy needle path due to microhemorrhage (blue arrows). (D), (I), (M): Tissue damage score (TDS) calculated and color coded based
on R2t* has been superimposed on the qGRE-T1w images. TDS map shows the heterogeneity of damage in the lesion. Higher TDS represents
lower R2t*, consistent with more severe tissue damage and/or greater edema. (E): Mean TDS in the left parieto-occipital lesion at three visits.
Decreasing mean TDS in the lesion suggests improving tissue integrity over the 14 months. (F), (J), (N): R2c* images generated by filtering out
free water contribution to R2t*, allowing better visualization of optic radiation damage (arrows are the same as in R2t* images).
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Discussion
We previously demonstrated that the qGRE R2t* metric7
can be used for in vivo evaluation of cortical neuronal
density in healthy brain.8 In accord, reduction in cortical
R2t* was significantly correlated with cognitive impairment in patients with both MS and Alzheimer Disease,9,14
suggesting that the amount and degree of cortical GM tissue damage can be estimated via voxel-wise R2t*. We
have also demonstrated that reductions in cortical R2t*
are more sensitive to clinical dysfunction than are reductions in cortical thickness in patients with MS.9
Here, we have examined associations of brain biopsy
results with qGRE-derived R2t* and R2c* metrics (the latter used to highlight WM tracts) in a man with inflammatory CNS demyelination with relative axonal sparing
who was eventually diagnosed with MS. The biopsied
lesion was active, given the histological presence of
numerous macrophages and T cells around vessels and in
CNS parenchyma, along with contrast enhancement on
clinical MRI. The two smaller nonspecific lesions were
not biopsied, but in retrospect are presumed to also be
demyelinating lesions in this young man without comorbidities that might invoke other etiologies.
We also correlated qGRE metrics with clinical evolution on three visits spanning more than a year. At the
first scan, high mean TDS in the parieto-occipital lesion
corresponded with severe speech, language and visual deficits. By the third scan, substantially lower mean TDS was
observed, in agreement with the progressive clinical
improvement in speech, language, and visual function.
The R2t* measurement in WM is affected by all tissue/
cellular constituents, that is, lipids, proteins, iron etc.
Consequently, loss of any of these components will lead
to R2t* reduction, as seen in the lesion.
Since R2c* highlights myelinated fiber tracts by filtering
out contributions of free water, it was applied to evaluate
tissue damage in the left optic radiation apart from
edema. On the initial scan, reduced R2c* suggested
demyelination of the left optic radiation, consistent with
the patient’s right homonymous hemianopia. Although
edema reduces R2t*, the reduced R2c* indicated that
pathology more than just edema was present, in agreement with histopathological results. At the second and
third qGRE scans, R2c* contrast was more apparent in
the left optic radiation, in concert with the progressive
improvement of his right homonymous hemianopia to
become an inferior right quadrantanopia. Hypothetically,
the increase in both, R2c* and R2t* might indicate
remyelination.
This study has a few limitations. The histopathological
data were only acquired at the beginning of the qGRE
study. Without serial histopathological data, we were
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unable to directly confirm myelin loss, remyelination, and
other disease related processes at later time-points. Also,
the histopathology from a small biopsied area might not
represent the pathology of the whole lesion. We followed
the patient for only 14 months, whereas lesion evolution
may be continuing for longer. Although the two-compartment model to provide R2c* relaxation achieves greater
specificity by filtering out free water within R2*, R2c* has
lower numerical accuracy compared with R2t*, due to
additional fitting parameters in the two-compartment
model. Thus, we used R2t* rather than R2c* for TDS calculation.
In summary, we demonstrated in vivo sensitivity of the
qGRE MRI to histopathology-verified inflammatory
demyelination in a person who ultimately turned out to
have MS. Compared with the standard FLAIR images,
qGRE not only identified the lesion but also quantified
the heterogeneous tissue damage within the lesion by
TDS, and directly visualized WM tracts by R2c*.
Together, these results support qGRE metrics as potential
quantitative and qualitative in vivo biomarkers for CNS
demyelination and tissue damage.
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Supporting Information
Additional supporting information may be found online
in the Supporting Information section at the end of the
article.
Figure S1. Clinical FLAIR images show the large biopsied
lesion and two small lesions in the left frontal lobe. (a),
(b), (c) correspond to disease onset. (d), (e), (f) correspond to 1 month after disease onset. (g), (h), (i) correspond to 5 months after biopsy. Red arrows point at the
small lesions in the left frontal lobe.
Figure S2. The R2t* values in the contralateral side of the
biopsied lesion. A region of interest similar in size to the
lesion that was biopsied was placed in the contralateral
side. The R2t* values were measured in the same region
for each visit. Results for R2t* values in the contralateral
side were close to the normal healthy control value (20.1
s-1) and showed little variation across the three visits. At
the same time, R2t* in the lesion progressively decreased
(up to 60%) (Fig. 2)
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